|
Clinical Trials and Observations
Citations 141-150 of 2742 total displayed.
|
Past content
(since May 1998):
|
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
- Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin-Yang Li, and Animesh Pardanani
Blood 2009; 113: 5727-5736.
[Abstract]
[Full text]
[PDF]
Hodgkin lymphoma in the Swiss HIV Cohort Study
- Gary M. Clifford, Martin Rickenbach, Mauro Lise, Luigino Dal Maso, Manuel Battegay, Julia Bohlius, Emmanuelle Boffi El Amari, Urs Karrer, Gernot Jundt, Andrea Bordoni, Silvia Ess, Silvia Franceschi, and for the Swiss HIV Cohort Study
Blood 2009; 113: 5737-5742.
[Abstract]
[Full text]
[PDF]
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma
- Weiyun Z. Ai, Robert Tibshirani, Behnaz Taidi, Debra Czerwinski, and Ronald Levy
Blood 2009; 113: 5743-5746.
[Abstract]
[Full text]
[PDF]
Comparable survival between HIV+ and HIV– non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
- José L. Díez-Martín, Pascual Balsalobre, Alessandro Re, Mariagrazia Michieli, José M. Ribera, Carmen Canals, Eulogio Conde, Anne Rosselet, Ian Gabriel, Rosario Varela, Bernardino Allione, Kate Cwynarski, Philippe Genet, Ildefonso Espigado, Pierre Biron, Norbert Schmitz, Anne E. Hunter, Augustin Ferrant, Gaelle Guillerm, Mark Hentrich, Manuel Jurado, Pascual Fernández, David Serrano, Giuseppe Rossi, and Anna Sureda, on behalf of the European Group for Blood and Marrow Transplantation Lymphoma Working Party
Blood 2009; 113: 6011-6014.
[Abstract]
[Full text]
[PDF]
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
- Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachée, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, and Ivo Abraham
Blood 2009; 113: 5401-5411.
[Abstract]
[Full text]
[PDF]
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer, Jerry A. Katzmann, Neil E. Caporaso, Richard B. Hayes, Angela Dispenzieri, Shaji Kumar, Raynell J. Clark, Dalsu Baris, Robert Hoover, and S. Vincent Rajkumar
Blood 2009; 113: 5412-5417.
[Abstract]
[Full text]
[PDF]
A monoclonal gammopathy precedes multiple myeloma in most patients
- Brendan M. Weiss, Jude Abadie, Pramvir Verma, Robin S. Howard, and W. Michael Kuehl
Blood 2009; 113: 5418-5422.
[Abstract]
[Full text]
[PDF]
Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction
- Patrick R. Hagner, Krystyna Mazan-Mamczarz, Bojie Dai, Sharon Corl, X. Frank Zhao, and Ronald B. Gartenhaus
Blood 2009; 113: 5526-5535.
[Abstract]
[Full text]
[PDF]
Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility
- Jeffrey A. Knight, Andrew D. Skol, Abhijit Shinde, Darcie Hastings, Richard A. Walgren, Jin Shao, Thelma R. Tennant, Mekhala Banerjee, James M. Allan, Michelle M. Le Beau, Richard A. Larson, Timothy A. Graubert, Nancy J. Cox, and Kenan Onel
Blood 2009; 113: 5575-5582.
[Abstract]
[Full text]
[PDF]
JAK2V617F mutation for the early diagnosis of Ph– myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- Francesco Dentali, Alessandro Squizzato, Lorenza Brivio, Lorena Appio, Leonardo Campiotti, Mark Crowther, Anna Maria Grandi, and Walter Ageno
Blood 2009; 113: 5617-5623.
[Abstract]
[Full text]
[PDF]
|
|
